Eva Caroff

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Aortic Dissection

Extracorporeal Membrane Oxygenation

Top Venues

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Emmanuel A Meyer, Andrew L Croxford, Carmela Gnerre, Paulina Kulig, Mark J Murphy, Elise M Jacob, Gabriel Schäfer, Sylvia Richard-Bildstein, Hamed Aissaoui, Patrick Bouis, Eric A Ertel, Ruben de Kanter, Marcel P Keller, Urs Lüthi, Eva Caroff
Discovery of the Clinical Candidate IDOR-1117-2520: A Potent and Selective Antagonist of CCR6 for Autoimmune Diseases. Journal of medicinal chemistry 67 (10) (2024)
Francis Hubler, Dorte Renneberg, Hervé Siendt, Simon Stamm, Kurt Hilpert, Eva Caroff, Stephane Delahaye, Sylvie Froidevaux, Mark J Murphy
Discovery and Characterization of a New Class of C5aR1 Antagonists Showing In Vivo Activity. Journal of medicinal chemistry 67 (5) (2024)
Francis Hubler, Dorte Renneberg, Hervé Siendt, Simon Stamm, Kurt Hilpert, Eva Caroff, Stephane Delahaye, Sylvie Froidevaux, Mark J Murphy
Discovery and Characterization of a New Class of C5aR1 Antagonists Showing In Vivo Activity. Journal of medicinal chemistry 67 (5) (2024)
Emmanuel A Meyer, Andrew L Croxford, Carmela Gnerre, Paulina Kulig, Mark J Murphy, Elise M Jacob, Gabriel Schäfer, Sylvia Richard-Bildstein, Hamed Aissaoui, Patrick Bouis, Eric A Ertel, Ruben de Kanter, Marcel P Keller, Urs Lüthi, Eva Caroff
Discovery of the Clinical Candidate IDOR-1117-2520: A Potent and Selective Antagonist of CCR6 for Autoimmune Diseases. Journal of medicinal chemistry (2024)
Emmanuel A Meyer, Päivi Äänismaa, Eric A Ertel, Eva Hühn, Daniel S Strasser, Markus Rey, Mark J Murphy, Marianne M Martinic, Laetitia Pouzol, Sylvie Froidevaux, Marcel P Keller, Eva Caroff
Discovery of Clinical Candidate ACT-777991, a Potent CXCR3 Antagonist for Antigen-Driven and Inflammatory Pathologies. Journal of medicinal chemistry (2023)
Emmanuel A Meyer, Päivi Äänismaa, Eric A Ertel, Eva Hühn, Daniel S Strasser, Markus Rey, Mark J Murphy, Marianne M Martinic, Laetitia Pouzol, Sylvie Froidevaux, Marcel P Keller, Eva Caroff
Discovery of Clinical Candidate ACT-777991, a Potent CXCR3 Antagonist for Antigen-Driven and Inflammatory Pathologies. Journal of medicinal chemistry 66 (6) (2023)
Emmanuel A Meyer, Päivi Äänismaa, Eric A Ertel, Eva Hühn, Daniel S Strasser, Markus Rey, Mark J Murphy, Marianne M Martinic, Laetitia Pouzol, Sylvie Froidevaux, Marcel P Keller, Eva Caroff
Discovery of Clinical Candidate ACT-777991, a Potent CXCR3 Antagonist for Antigen-Driven and Inflammatory Pathologies. Journal of medicinal chemistry 66 (6) (2023)
Emmanuel A Meyer, Päivi Äänismaa, Sylvie Froidevaux, Marcel Keller, Luca Piali, Eva Caroff
Discovery and In Vivo Evaluation of ACT-660602: A Potent and Selective Antagonist of the Chemokine Receptor CXCR3 for Autoimmune Diseases. Journal of medicinal chemistry 65 (17) (2022)
Eva Caroff, Emmanuel A Meyer, Päivi Äänismaa, Sylvie Froidevaux, Marcel Keller, Luca Piali
Design, Synthesis, and Pharmacological Evaluation of Benzimidazolo-thiazoles as Potent CXCR3 Antagonists with Therapeutic Potential in Autoimmune Diseases: Discovery of ACT-672125. Journal of medicinal chemistry 65 (17) (2022)